WORLD US FDA approves Moderna, Johnson & Johnson COVID-19 boosters, 'mix and match' booster dose

WORLD

US FDA approves Moderna, Johnson & Johnson COVID-19 boosters, 'mix and match' booster dose

Xinhua

07:33, October 21, 2021

WASHINGTON, Oct. 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday authorized booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson.

Paramedic Jose Colon administers a shot of the Pfizer-BioNTech COVID-19 vaccine to Eric Hernandez at a mobile vaccination site in Orlando. (File photo: VCG)

The FDA also authorized "mix and match" booster dose for currently available approved COVID-19 vaccines.

A single booster dose of any of the available COVID-19 vaccines may be administered as a "mix and match" booster dose following completion of primary vaccination with a different available COVID-19 vaccine, according to the FDA.

The agency approved the use of a single booster dose of the Moderna COVID-19 vaccine at least 6 months after completion of the primary shots to people 65 years of age and older, 18 through 64 years of age at high risk of severe COVID-19, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.

As for the Johnson & Johnson booster dose, the FDA authorized the use of a single booster dose at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.

The decision came after an FDA advisory committee voted last week to recommend authorizing Moderna and Johnson & Johnson's COVID-19 booster doses.


Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue